Serum levels and ApaI polymorphism of insulin-like growth factor 2 on intrauterine growth restriction infants

J Matern Fetal Neonatal Med. 2018 Jun;31(11):1470-1476. doi: 10.1080/14767058.2017.1319921. Epub 2017 May 1.

Abstract

Purpose: The aim of our study was to evaluate the IGF2 and IGF2R plasmatic level and IGF2-ApaI polymorphism on infants with intrauterine growth restriction (IUGR).

Materials and methods: A transversal study was conducted at the Neonatology Ward of the Gynecology Clinic I, Emergency Hospital Cluj-Napoca on neonates with IUGR who were discharged during June 2014 and June 2015. The serum levels of IGF2 and IGF2R were obtained by using ELISA method and IGF2-ApaI polymorphism by taking PCR-RFLP analysis.

Results: Forty infants with IUGR and 21 infants of appropriate gestational age (AGA) were evaluated. The serum levels of IGF2 proved higher on the A/G genotype when the IUGR group was compared with AGA (p value = .048). The G allele proved significantly more frequent in both the IUGR and the AGA group compared with the A allele (p < .002). Neither any allele nor any genotype proved a risk factor for IUGR (p value > .3). The A/G genotype proved significantly more frequent on term infants compared with preterm infants (p value = .039).

Conclusions: The infant with IUGR has a higher serum level of IGF2 if has A/G IGF2-ApaI genotype and higher values of IGF2R if it has the A/A genotype.

Keywords: Intrauterine growth restriction (IUGR); insulin-like growth factor 2 (IGF2); insulin-like growth factor 2 receptor (IGF2R); single nucleotide polymorphisms (SNPs).

MeSH terms

  • Adult
  • Deoxyribonucleases, Type II Site-Specific
  • Female
  • Fetal Growth Retardation / blood*
  • Fetal Growth Retardation / genetics*
  • Humans
  • Infant, Newborn
  • Insulin-Like Growth Factor II / genetics*
  • Insulin-Like Growth Factor II / metabolism*
  • Male
  • Pregnancy
  • Receptor, IGF Type 2 / metabolism*

Substances

  • IGF2 protein, human
  • Receptor, IGF Type 2
  • Insulin-Like Growth Factor II
  • Deoxyribonucleases, Type II Site-Specific
  • GGGCCC-specific type II deoxyribonucleases